Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 2/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 4/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.43 |
| ▸ | AMY2A | P04746 | 3/20 | 0.43 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.43 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.43 |
| ▸ | FGF1 | P05230 | 1/20 | 0.40 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MGAM | O43451 | 2/20 | 0.39 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14920478 | 0.97 | LGALS3 (0.47) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL15720609 | 0.97 | LGALS3 (0.47) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL15709547 | 0.96 | LGALS3 (0.46) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL15226769 | 0.96 | LGALS3 (0.46) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL17654900 | 0.95 | LGALS3 (0.49) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL14616535 | 0.95 | LGALS3 (0.49) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL15546804 | 0.93 | LGALS8 (0.43) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL15545709 | 0.93 | CD69 (0.47) | CD69LGALS3LGALS8LGALS4LGALS9 | |
| SCHEMBL17767385 | 0.92 | LGALS8 (0.44) | CD69LGALS3LGALS8LGALS4AMY2A | |
| SCHEMBL2237219 | 0.90 | LGALS8 (0.49) | CD69LGALS3LGALS8LGALS4AMY2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200108127-A1 | HYPOTONIC COMPOSITION FOR FAT DECOMPOSITION AND METHOD FOR PREPARING SAME | LEE KYOUNG LACK (KR) | 2020-04-09 | — | — | US | claimed |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-05-08 | — | — | US | disclosed |
| US-12226527-B2 | Gel formulations for local drug release | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-02-18 | — | — | US | disclosed |
| CN-115501172-A | Gel formulations for topical drug delivery | 丹麦技术大学 | 2022-12-23 | — | — | CN | disclosed |
| US-20220339285-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-107249570-B | Gel formulations for topical drug delivery | 丹麦技术大学 | 2022-08-09 | — | — | CN | disclosed |
| US-11331396-B2 | Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2022-05-17 | — | — | US | disclosed |
| EP-3982922-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | Technical University of Denmark (DK) | 2022-04-20 | — | — | EP | disclosed |
| US-20210386669-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2021-12-16 | — | — | US | disclosed |
| US-11065201-B2 | Gel formulations for local drug release | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2021-07-20 | — | — | US | disclosed |
| US-20150152462-A1 | Carbohydrate Esters as Inducers for Gene Expression | SOPHORO BIOTECHNOLOGIES, LLC (US) | 2015-06-04 | — | — | US | disclosed |
| EP-2875143-A1 | CARBOHYDRATE ESTERS AS INDUCERS FOR GENE EXPRESSION | Sophoro Biotechnologies LLC (US) | 2015-05-27 | — | — | EP | disclosed |
| CN-104471071-A | Sugar esters as inducers of gene expression | SOPHORO BIOTECHNOLOGIES LLC | 2015-03-25 | — | — | CN | disclosed |
| WO-2014015179-A1 | CARBOHYDRATE ESTERS AS INDUCERS FOR GENE EXPRESSION | SOPHORO BIOTECHNOLOGIES, LLC (US) | 2014-01-23 | — | — | WO | disclosed |
| US-7507675-B2 | Silicon substrate is irradiated to produce silicon oxide; reacted with 1-alkene or alkylne; Field Effect Transistor (FET) structures, gate of FET being formed by functionalized organic monolayer containing oligosaccharides or oligopeptides, capable of interacting with biological substance; biosesors | ASML NETHERLANDS B.V. (NL) | 2009-03-24 | — | — | US | disclosed |
| US-20070178707-A1 | Device manufacturing method and device | ASML NETHERLANDS B.V. (NL) | 2007-08-02 | — | — | US | disclosed |
| WO-2005001461-A2 | BIOSENSOR AND METHOD OF PREPARATION | ASML NETHERLANDS B.V. (NL) | 2005-01-06 | — | — | WO | disclosed |
| EP-0071598-A4 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS. | BAZZANO GAIL S | 1983-06-08 | — | — | EP | disclosed |
| EP-0071598-A1 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS. | BAZZANO GAIL S | 1983-02-16 | — | — | EP | disclosed |
| WO-1982002833-A1 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FUR-BEARING ANIMALS | BAZZANO GAIL SANSONE | 1982-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11331396-B2 | Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility | HEXB, GLB1, GOLT1B | CD69 1436/4885LGALS3 64/4885LGALS8 243/4885 |
| US-11065201-B2 | Gel formulations for local drug release | TREH, GALE, SLC2A8 | CD69 1327/4885LGALS3 40/4885LGALS8 19/4885 |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TREH, GALE, SLC2A8 | CD69 1327/4885LGALS3 40/4885LGALS8 19/4885 |
| US-20210386669-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TREH, GALE, SLC2A8 | CD69 1327/4885LGALS3 40/4885LGALS8 19/4885 |
| US-12226527-B2 | Gel formulations for local drug release | TREH, GALE, SLC2A8 | CD69 1327/4885LGALS3 40/4885LGALS8 19/4885 |
| US-20220339285-A1 | DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE | LIPA, LIPE, CEL | CD69 1575/4885LGALS3 257/4885LGALS8 190/4885 |
| US-20150152462-A1 | Carbohydrate Esters as Inducers for Gene Expression | HSD17B14, MGAM, ATF4 | CD69 386/4885LGALS3 738/4885LGALS8 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.